BackNOV Overview
NOV Inc

NOV Target Price

Analysts' average 12-month price target for NOV is $22.

Get informed when a big investor buys or sells

+ Follow

Share Price

$20.99

Average Target Price

$21.803.9% upside

5 analysts in the last 4 months

High: $26 | Low: $19

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-07-15Morgan Stanley$210% upsideOpen
2026-07-08Susquehanna$224.8% upsideOpen
2026-06-04Capital One Financial$2623.9% upsideOpen
2026-06-03Goldman Sachs$199.5% downsideOpen
2026-05-07BarclaysDavid Anderson$210% upsideOpen
2026-04-29Susquehanna$2414.3% upsideOpen
2026-04-15Morgan Stanley$204.7% downsideOpen
2026-02-09Piper SandlerDerek Podhaizer$1814.2% downsideOpen
2026-02-06Evercore ISIJason Bandel$199.5% downsideOpen
2026-02-06Stifel Nicolaus$210% upsideOpen
2026-02-06Susquehanna$210% upsideOpen
2026-01-15RBC CapitalKeith Mackey$210% upsideOpen
2026-01-14Goldman Sachs$1719% downsideOpen
2026-01-07SusquehannaCharles Minervino$204.7% downsideOpen
2025-12-18Piper SandlerDerek Podhaizer$1719% downsideOpen
2025-12-17Barclays$1528.5% downsideOpen
2025-12-15Morgan StanleyJoe Laetsch$1623.8% downsideOpen
2025-11-11BarclaysDavid Anderson$1338.1% downsideOpen
2025-11-05Goldman SachsAti Modak$1433.3% downsideOpen
2025-10-30Barclays$1433.3% downsideOpen
2025-10-29Stifel Nicolaus$199.5% downsideOpen
2025-10-29RBC Capital$199.5% downsideOpen
2025-10-28Raymond JamesJames Rollyson$1719% downsideOpen
2025-07-30Susquehanna$1719% downsideOpen
2025-04-15Stifel NicolausStephen Gengaro$239.6% upsideOpen
2025-03-24RBC CapitalKeith Mackey$224.8% upsideOpen
2024-12-18BarclaysDavid Anderson$1242.8% downsideOpen
2024-10-11Stifel NicolausStephen Gengaro$2519.1% upsideOpen
2024-10-10BMO CapitalPhillip Jungwirth$204.7% downsideOpen
2024-09-16Morgan StanleyDaniel Kutz$239.6% upsideOpen
2024-07-30BarclaysDavid Anderson$204.7% downsideOpen
2023-02-08Susquehanna$2938.2% upsideOpen
2022-07-29Morgan Stanley$199.5% downsideOpen
2022-07-13Morgan Stanley$1814.2% downsideOpen
2022-07-13Goldman Sachs$1623.8% downsideOpen
2022-06-08Barclays$224.8% upsideOpen
2022-05-02Barclays$204.7% downsideOpen
2022-02-04Evercore ISIJames West$224.8% upsideOpen
2021-12-09Cowen & Co.Marc Bianchi$199.5% downsideOpen
2021-10-11Morgan StanleyConnor Lynagh$1719% downsideOpen
2021-07-19BMO CapitalPhillip Jungwirth$1528.5% downsideOpen
2021-05-04Coker PalmerVaibhav Vaishnav$1242.8% downsideOpen

NOV (NOV) FAQ

NOV's target price stands at $22. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

The Street's average target of $22 for NOV implies 3.9% upside versus today's price ($20.99). Positive implied upside usually reflects optimism on growth or margins, while a large downside can signal valuation or fundamental concerns. Check recommendation mix and recent target changes for more context.

The history chart shows how NOV's target price evolved across reporting periods, while the comparison chart places NOV next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Industrials, target price is commonly used to spot outliers. NOV's reading of $22 is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.